facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

GAZYVA- obinutuzumab injection, solution, concentrate


  1. Advise Patients To Seek Immediate Medical Attention For Any Of The Following:
  2. Advise Patients Of The Need For:

Advise Patients To Seek Immediate Medical Attention For Any Of The Following: 

Advise Patients Of The Need For: 

Advise pregnant women of potential fetal B-cell depletion[seeUse in Specific Populations (8.1)].

GAZYVA(obinutuzumab)

Manufactured by:
Genentech, Inc.
A Member of the Roche Group
South San Francisco, CA 94080-4990
U.S. License No. 1048

GAZYVA is a registered trademark of Genentech, Inc.
2017 Genentech, Inc.

Representative sample of labeling (see theHOW SUPPLIEDsection for complete listing):



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com